American Century Companies’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-200,940
| Closed | -$2.37M | – | 1388 |
|
|
2019
Q2 | $2.37M | Buy |
200,940
+54,719
| +37% | +$644K | ﹤0.01% | 1002 |
|
|
2019
Q1 | $2M | Sell |
146,221
-7,166
| -5% | -$97.8K | ﹤0.01% | 995 |
|
|
2018
Q4 | $1.57M | Sell |
153,387
-18,589
| -11% | -$191K | ﹤0.01% | 1008 |
|
|
2018
Q3 | $2.86M | Sell |
171,976
-1,259
| -0.7% | -$21K | ﹤0.01% | 964 |
|
|
2018
Q2 | $2.74M | Buy |
173,235
+62,704
| +57% | +$991K | ﹤0.01% | 962 |
|
|
2018
Q1 | $1.4M | Buy |
110,531
+8,258
| +8% | +$105K | ﹤0.01% | 1047 |
|
|
2017
Q4 | $1.17M | Sell |
102,273
-458
| -0.4% | -$5.24K | ﹤0.01% | 1078 |
|
|
2017
Q3 | $1.26M | Buy |
102,731
+11,679
| +13% | +$143K | ﹤0.01% | 1111 |
|
|
2017
Q2 | $1.04M | Buy |
91,052
+20,566
| +29% | +$236K | ﹤0.01% | 1135 |
|
|
2017
Q1 | $1.47M | Buy |
70,486
+3,815
| +6% | +$79.3K | ﹤0.01% | 1091 |
|
|
2016
Q4 | $1.39M | Sell |
66,671
-13,827
| -17% | -$288K | ﹤0.01% | 1088 |
|
|
2016
Q3 | $2.64M | Buy |
80,498
+3,254
| +4% | +$107K | ﹤0.01% | 1018 |
|
|
2016
Q2 | $1.93M | Buy |
77,244
+4,274
| +6% | +$107K | ﹤0.01% | 1032 |
|
|
2016
Q1 | $1.79M | Sell |
72,970
-2,767
| -4% | -$67.8K | ﹤0.01% | 1025 |
|
|
2015
Q4 | $2.5M | Buy |
75,737
+6,829
| +10% | +$226K | ﹤0.01% | 989 |
|
|
2015
Q3 | $2.26M | Buy |
68,908
+5,925
| +9% | +$194K | ﹤0.01% | 1001 |
|
|
2015
Q2 | $3.34M | Sell |
62,983
-12,353
| -16% | -$654K | ﹤0.01% | 949 |
|
|
2015
Q1 | $2.17M | Buy |
+75,336
| New | +$2.17M | ﹤0.01% | 1031 |
|